Team IP is at #AUA25 with a big first day - 4️⃣ talks! Hashim U. Ahmed: focal therapy debate (Plenary; 08:30) Alexander Light: validation of the #TARGET score (MP04; 09:30) and Rezum 5y outcomes (IP03; 09:30) Chase Ng: #RAPID 5y follow up post-negative MRI/biopsy (PD04; 09:30)

Powerful messages from Hashim U. Ahmed in the focal therapy plenary crossfire debate Most intermediate risk cases are suitable, focal therapy is very effective, and the functional outcomes are superior. Surgeon training is crucial #AUA25 🇺🇸

Grateful for this opportunity to share our findings with our colleagues across the Atlantic to optimise and standardise ways to diagnose csPCa while minimising over-diagnosis and redundant biopsies Special thanks to Hashim U. Ahmed & Taimur Shah for mentorship and support

Another big day for Team IP with 3️⃣ presentations! 1️⃣ Hashim U. Ahmed (for Martin J. Connor): results of the #IP2ATLANTA RCT pilot (PD13: 10:50) 2️⃣ Chase Ng: 5y follow-up of ASAP & HGPIN in #RAPID (GG posters) 3️⃣ Archana Gopalakrishnan: update on #IB1LaserCOMPLETE (IP11; 09:30)

Building on our #IP8FLUORESCE study is #IB1LaserCOMPLETE - using ex vivo fluoresce confocal microscopy to establish muscle status in TURBT. Presented here by Archana Gopalakrishnan Recruitment is under way - watch this space for results soon! #AUA25

Thank you Victor for highlighting this piece of work by Imperial Prostate, which cements the oncological efficacy of the MRI-led RAPID prostate cancer diagnostic pathway. #LATP #mpMRI #AUA25

In further #RAPID data, Chase Ng shows that patients discharged from a pre-biopsy MRI pathway with ASAP or HGPIN do not have a greater risk of subsequent csPCa or treatment than patients discharged without #AUA25 Alexander Light

Update of #IP7PACIFIC presented by Alexander Light at #AUA25 This will be the first trial to provide definitive evidence comparing bpMRI vs mpMRI, alongside fusion vs cognitive biopsy >1200 patients recruited across the UK - watch this space

That’s a wrap on #AUA25 for Team IP! See you in Washington DC for #AUA26! 🇺🇸

Next up Chase Ng presents the 5 year oncological outcomes of men with initial negative #ProstateCancer investigations in the #RAPID pathway 🏃

Nikhil Mayor presents outcomes from the first prospective, blinded assessment of #FCM with the #HistologScanner in #RadicalProstatectomy #IP8FLUORESCE

Brilliant prostate cancer abstract session this morning with 4️⃣ presentations from Team IP at #BAUS25 Huge breadth covered including MRI diagnostics, focal therapy, intraoperative margin assessment, and cytoreduction strategies in metastatic disease

Fantastic overview of diagnostic and therapeutic strategies in radiorecurrent prostate cancer by Taimur Shah Key takeaways - MRI highly sensitive for local disease (even more so with PSMA PET/CT) & focal therapy as effective as RP in the salvage setting #BAUS25

Timely update on surgical health policy; progress has been made but there are still multiple, interlocking issues. Will the new global health architecture address these? thelancet.com/journals/lance… World Health Organization (WHO) World Bank

Rpt TURBT for NMIBC ⬆️ morbidity, cost, carbon footprint Could office-based TULA be a safe de-escalation strategy? TULA vs TURBT (EORTC risk-matched) 📈Higher recurrence 📊Similar progression 📉Low muscle invasion 👫Good OS&CSS Imperial Urology bjui-journals.onlinelibrary.wiley.com/doi/10.1002/bc…

The STARS Urology ST3 Interview Course 2026 is back! Registration will go live @ 09:00 31/10/25. There are very limited spaces so make sure to sign up as soon as possible! BSoT